Lactose monohydrate, chemically represented by the formula C12H22O11·H2O and identified by CAS 10039-26-6, is a disaccharide sugar derived from milk. Its structure, consisting of galactose and glucose units linked by a beta-1,4 glycosidic bond, along with a molecule of water of crystallization, endows it with specific properties highly valuable in pharmaceutical science. NINGBO INNO PHARMCHEM CO.,LTD. offers insights into these properties and their impact on drug development.

One of the most significant properties of lactose monohydrate is its excellent compressibility. This characteristic stems from its crystalline structure, which allows it to deform plastically under pressure, forming strong bonds with adjacent particles. This makes it an ideal candidate for direct compression tableting, a manufacturing process that simplifies production and reduces costs. Its ability to be milled to various particle sizes also allows for optimization of flow and compaction behavior, essential for the 'lactose monohydrate uses in tablets' and 'lactose monohydrate as excipient' discussions.

The solubility of lactose monohydrate in water, while moderate, is sufficient for many pharmaceutical applications, including its use in solutions and suspensions. Its stability under typical storage conditions also ensures that drug formulations retain their intended characteristics over time. This stability is a key reason why it is considered a reliable 'lactose monohydrate pharmaceutical grade' ingredient.

In dry powder inhalers (DPIs), lactose monohydrate acts as a carrier for micronized drug particles. Its physical properties, such as particle size distribution and surface energy, are critical for efficient aerosolization and lung deposition of the drug. The interaction between the lactose carrier and the API is a complex area of study, and NINGBO INNO PHARMCHEM CO.,LTD. provides carefully characterized lactose monohydrate suitable for these sensitive applications.

The inherent biocompatibility and low toxicity of lactose monohydrate contribute to its safety profile as a pharmaceutical excipient. While lactose intolerance is a known condition, the small amounts used in most oral solid dosage forms are generally well-tolerated by the majority of the population. Nevertheless, manufacturers must consider potential patient sensitivities when formulating.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing pharmaceutical manufacturers with lactose monohydrate that adheres to rigorous quality control measures. By understanding the precise scientific requirements for excipients, we ensure that our products, including those specified by CAS 10039-26-6, support the development of effective and safe pharmaceutical products. Our commitment to quality makes us a trusted source for essential pharmaceutical ingredients.